SM Prime said that SMXCITE, together with SMX Manila, will offer over 35,000 square meters of combined space, further reinforcing the MOA Complex’s appeal as a destination for international ...

If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold under the brand names Victoza and Saxenda. Read on for everything ...

DUBLIN--(BUSINESS WIRE)--The "Liraglutide and Semaglutide Market by Type, by Route of Administration, by Application, by Distribution Channel, and by Region" report has been added to ...

As a result of the stronger than expected performance of DehydraTECH-processed liraglutide, the Company has made the decision to investigate further with human study GLP-1-H25-5 expected to be ...

The drug, liraglutide, is sold under the brand names Victoza and Saxenda. Liraglutide was not originally developed as a weight-loss treatment. Like semaglutide (Ozempic), it originally treated ...

Study reveals liraglutide's potential to regulate iron metabolism and improve glucose tolerance in a mouse model of hereditary hemochromatosis and obesity. Study: Liraglutide Impacts Iron ...

New research reveals that liraglutide, a GLP-1 receptor agonist, crosses the blood-brain barrier to target specific neurons, reducing appetite and promoting lasting weight loss. Liraglutide ...

Liraglutide (Saxenda; Novo Nordisk) significantly reduces body weight in children ages 6 to 11 with obesity when combined with changes in lifestyle, results of the SCALE Kids trial show. The mean ...

Nearly half (46%) of the liraglutide group versus 9% of the placebo group lost at least 5% of BMI (adjusted OR 6.3, 95% CI 1.4-28.8). Average body weight change was 1.6% with liraglutide and 10% ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got a placebo, according to a new study. Doctors say it can be extremely ...

Although the use of liraglutide has been shown to induce weight loss in adults and adolescents with obesity, its safety and efficacy have not been established in children. In this phase 3a trial ...

The obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the annual meeting of the European Association for the Study of Diabetes ...